Stocks: Sectors
- Energy
- Materials
- Industrials
- Consumer Discretionary
- Consumer Staples
- Health Care
- Financial
- Technology
- Utilities
Futures
Benchmarks
Forex
Industries
Comparative
Seasonal Start
Economic Data
Geovax Labs Inc. (NASD:GOVX) Seasonal Chart
|
GOVX Relative to the S&P 500 |
GOVX Relative to the Sector |
Geovax Labs Inc is US-based clinical-stage biotechnology company. It is engaged in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) vector vaccine platform. The development programs of the company focused on preventive vaccines against Human Immunodeficiency Virus (HIV), Zika Virus, hemorrhagic fever viruses, and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The product pipeline includes HIV-Clade B Preventive Vaccine, HIV-Clade B Immunotherapy, Hemorrhagic Fever Vaccines, Zika Vaccine, Malaria vaccine, and Cancer Immunotherapy.
To download GOVX seasonal chart data, please log in or Subscribe.
Stocks mentioned in this post: GOVX
Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
|
|